JP2012515723A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2012515723A5 JP2012515723A5 JP2011546449A JP2011546449A JP2012515723A5 JP 2012515723 A5 JP2012515723 A5 JP 2012515723A5 JP 2011546449 A JP2011546449 A JP 2011546449A JP 2011546449 A JP2011546449 A JP 2011546449A JP 2012515723 A5 JP2012515723 A5 JP 2012515723A5
- Authority
- JP
- Japan
- Prior art keywords
- dosage form
- pharmaceutical dosage
- lanthanum carbonate
- excipient
- drying
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000002552 dosage form Substances 0.000 claims 15
- 229910017569 La2(CO3)3 Inorganic materials 0.000 claims 13
- NZPIUJUFIFZSPW-UHFFFAOYSA-H lanthanum carbonate Chemical compound [La+3].[La+3].[O-]C([O-])=O.[O-]C([O-])=O.[O-]C([O-])=O NZPIUJUFIFZSPW-UHFFFAOYSA-H 0.000 claims 13
- 229960001633 lanthanum carbonate Drugs 0.000 claims 13
- 239000000546 pharmaceutical excipient Substances 0.000 claims 9
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 claims 6
- 239000007884 disintegrant Substances 0.000 claims 6
- 238000000034 method Methods 0.000 claims 4
- 238000000975 co-precipitation Methods 0.000 claims 3
- 238000004108 freeze drying Methods 0.000 claims 3
- 239000008184 oral solid dosage form Substances 0.000 claims 3
- 238000001694 spray drying Methods 0.000 claims 3
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 claims 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims 2
- WHNWPMSKXPGLAX-UHFFFAOYSA-N N-Vinyl-2-pyrrolidone Chemical compound C=CN1CCCC1=O WHNWPMSKXPGLAX-UHFFFAOYSA-N 0.000 claims 2
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 claims 2
- 229920002472 Starch Polymers 0.000 claims 2
- 229940075614 colloidal silicon dioxide Drugs 0.000 claims 2
- 229910052698 phosphorus Inorganic materials 0.000 claims 2
- 239000011574 phosphorus Substances 0.000 claims 2
- 229920000036 polyvinylpyrrolidone Polymers 0.000 claims 2
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 claims 2
- 229940069328 povidone Drugs 0.000 claims 2
- 235000012239 silicon dioxide Nutrition 0.000 claims 2
- 239000000377 silicon dioxide Substances 0.000 claims 2
- 229960001866 silicon dioxide Drugs 0.000 claims 2
- 239000008107 starch Substances 0.000 claims 2
- 235000019698 starch Nutrition 0.000 claims 2
- 229940032147 starch Drugs 0.000 claims 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims 2
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 claims 1
- 229930195725 Mannitol Natural products 0.000 claims 1
- 229910004298 SiO 2 Inorganic materials 0.000 claims 1
- 201000005991 hyperphosphatemia Diseases 0.000 claims 1
- 239000007788 liquid Substances 0.000 claims 1
- 235000010355 mannitol Nutrition 0.000 claims 1
- 239000000594 mannitol Substances 0.000 claims 1
- 239000000203 mixture Substances 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US14616209P | 2009-01-21 | 2009-01-21 | |
| US61/146,162 | 2009-01-21 | ||
| PCT/US2010/021573 WO2010085520A1 (en) | 2009-01-21 | 2010-01-21 | Disintegrable formulations of lanthanum carbonate |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2012515723A JP2012515723A (ja) | 2012-07-12 |
| JP2012515723A5 true JP2012515723A5 (cg-RX-API-DMAC7.html) | 2013-02-14 |
| JP5643227B2 JP5643227B2 (ja) | 2014-12-17 |
Family
ID=42356194
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2011546449A Expired - Fee Related JP5643227B2 (ja) | 2009-01-21 | 2010-01-21 | 炭酸ランタンの崩壊製剤 |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US8962036B2 (cg-RX-API-DMAC7.html) |
| EP (1) | EP2389070B1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP5643227B2 (cg-RX-API-DMAC7.html) |
| CA (1) | CA2748496C (cg-RX-API-DMAC7.html) |
| ES (1) | ES2433076T3 (cg-RX-API-DMAC7.html) |
| PL (1) | PL2389070T3 (cg-RX-API-DMAC7.html) |
| PT (1) | PT2389070E (cg-RX-API-DMAC7.html) |
| SI (1) | SI2389070T1 (cg-RX-API-DMAC7.html) |
| WO (1) | WO2010085520A1 (cg-RX-API-DMAC7.html) |
| ZA (1) | ZA201105577B (cg-RX-API-DMAC7.html) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH0640812B2 (ja) | 1987-10-28 | 1994-06-01 | 雪印乳業株式会社 | 醗酵室 |
| US8263119B2 (en) | 2010-12-01 | 2012-09-11 | Shire Llc | Capsule formulations containing lanthanum compounds |
| US8697132B2 (en) | 2010-12-01 | 2014-04-15 | Shire Llc | Capsule and powder formulations containing lanthanum compounds |
| WO2016051609A1 (ja) * | 2014-10-02 | 2016-04-07 | 東和薬品株式会社 | 粒度調整された炭酸ランタン水和物からなる医薬 |
| JP2016147827A (ja) * | 2015-02-12 | 2016-08-18 | 株式会社三和化学研究所 | 炭酸ランタン水和物を含有する医薬製剤 |
| CN112724039A (zh) | 2015-04-20 | 2021-04-30 | 艾德凡斯化学公司 | 包括烷基肟的涂料组合物 |
| EP4061340A4 (en) | 2019-11-21 | 2023-08-09 | Santa Farma Ilaç Sanayi A.S. | ORAL SOLID PHARMACEUTICAL COMPOSITIONS WITH LANTANHANE CARBONATE OCTAHYDRATE |
| CN115813867B (zh) * | 2022-12-01 | 2024-05-24 | 山东齐都药业有限公司 | 碳酸镧冻干片及其制备方法 |
| JP2025044388A (ja) * | 2023-09-20 | 2025-04-02 | 株式会社東芝 | 酸性ガス除去方法、酸性ガス吸収剤、および酸性ガス除去装置 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP3371531B2 (ja) * | 1994-04-20 | 2003-01-27 | 株式会社豊田中央研究所 | 触媒の製造方法 |
| GB9506126D0 (en) * | 1995-03-25 | 1995-05-10 | Johnson Matthey Plc | Pharmaceutical composition and method |
| GB0123400D0 (en) * | 2001-09-28 | 2001-11-21 | Novartis Ag | Organic compounds |
| US20040161474A1 (en) | 2002-05-24 | 2004-08-19 | Moerck Rudi E. | Rare earth metal compounds methods of making, and methods of using the same |
| DK2792363T3 (da) * | 2003-08-26 | 2016-09-26 | Shire Biopharmaceuticals Holdings Ireland Ltd | Farmaceutisk formulering, der omfatter lanthanforbindelser |
| US7381428B2 (en) * | 2003-08-26 | 2008-06-03 | Shire International Licensing B.V. | Stabilized lanthanum carbonate compositions |
| WO2007022466A2 (en) * | 2005-08-17 | 2007-02-22 | Altairnano, Inc. | Hyperphosphatemia in domestic animals: compositions and methods of treatment |
| GB0612695D0 (en) * | 2006-06-27 | 2006-08-09 | Univ Gent | Process for preparing a solid dosage form |
-
2010
- 2010-01-21 PL PL10733831T patent/PL2389070T3/pl unknown
- 2010-01-21 US US13/145,589 patent/US8962036B2/en not_active Expired - Fee Related
- 2010-01-21 JP JP2011546449A patent/JP5643227B2/ja not_active Expired - Fee Related
- 2010-01-21 WO PCT/US2010/021573 patent/WO2010085520A1/en not_active Ceased
- 2010-01-21 PT PT107338311T patent/PT2389070E/pt unknown
- 2010-01-21 EP EP10733831.1A patent/EP2389070B1/en active Active
- 2010-01-21 CA CA2748496A patent/CA2748496C/en active Active
- 2010-01-21 ES ES10733831T patent/ES2433076T3/es active Active
- 2010-01-21 SI SI201030369T patent/SI2389070T1/sl unknown
-
2011
- 2011-07-28 ZA ZA2011/05577A patent/ZA201105577B/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES2410154T3 (es) | Metasilicatos de calcio y métodos para fabricarlos | |
| CN101888834A (zh) | 口服分散片 | |
| UY32599A (es) | Formulación oral sólida de abt-263 | |
| JP2012519201A5 (cg-RX-API-DMAC7.html) | ||
| JP2010530846A5 (cg-RX-API-DMAC7.html) | ||
| ITMI20071971A1 (it) | Composizione farmaceutica per la somministrazione sublinguale di progesterone, e metodo per la sua preparazione | |
| US8962036B2 (en) | Disintegrable formulations of lanthanum carbonate | |
| JP2014500246A5 (cg-RX-API-DMAC7.html) | ||
| JP2011026335A5 (cg-RX-API-DMAC7.html) | ||
| US6984377B2 (en) | Oral care products comprising calcium metasilicates | |
| AU2011247642B2 (en) | Orally disintegrating tablet containing acarbose | |
| CN108261399A (zh) | 奥氮平口腔崩解片及其制备方法 | |
| JP5291324B2 (ja) | 口腔内崩壊錠 | |
| JP2016503066A5 (cg-RX-API-DMAC7.html) | ||
| CN102512402B (zh) | 一种治疗胃及十二指肠溃疡药物新的制剂及制备方法 | |
| JP2017002038A (ja) | 固形製剤 | |
| CN102018721B (zh) | 一种碳酸钙二甲硅油咀嚼片及其制备方法 | |
| JP2011173848A (ja) | 口腔内速崩壊錠 | |
| JP2010270042A (ja) | グリチルリチン酸の安定化方法 | |
| CN101352440B (zh) | 一种美愈伪麻缓释制剂及其制备方法 | |
| CN104173302A (zh) | 一种奥美沙坦酯片剂及其制备方法 | |
| CN101152156A (zh) | 多潘立酮口腔崩解片及其制备方法 | |
| JP2015205852A (ja) | 球状の無水リン酸水素カルシウムを用いた崩壊性に優れた錠剤、および球状の無水リン酸水素カルシウムを賦形剤として用いた崩壊性に優れた錠剤 | |
| CN100490816C (zh) | 阿奇霉素口腔崩解片及其制备方法 | |
| JP2011201904A (ja) | サリチル酸類含有経口組成物 |